Fact Based List:
The 10 drugs for which companies spent the most in payments to physicians in 2015
Submitted by Anonymous on Wed, 12/14/2016 - 18:47
- Xarelto ($28.4 Million)
- Humira ($24.9 Million)
- Invokana ($20.9 Million)
- Viekira ($19.2 Million)
- Eliquis ($18.8 Million)
- Bydureon ($18.5 Million)
- Androgel ($15.3 Million)
- Synthroid ($14.7 Million)
- Lupron ($14.3 Million)
- Victoza ($11.9 Million)
Source: Pro Publica
Source URL: https://www.propublica.org/article/updated-dollars-for-docs-...
List Ratings: |
Lists You Might Also Be Interested In
- AMA survey: 10 Ways Physicians Are Using AI
- Ten States With Highest Percentage of Office-Based Physicians Using Any EMR/EHR System
- Top Barriers to Connected Healthcare Adoption by U.S. Physicians: ZS survey
- Crowdsourced Physicians: 10 Ways to Decrease Healthcare Costs
- National Physicians Alliance: The Top 5 Ways To Improve Primary Care; Pediatrics
Login or register to post comments